Cargando…
Rexin-G(®), a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report
Soft tissue sarcoma is a rare neoplasm of mesenchymal origin, accounting for only ~1% of all adult cancers and consisting of 75 histological subtypes. In the present report, the unique case of a 14 year-old female with metastatic malignant peripheral nerve sheath tumor (formerly, malignant melanotic...
Autores principales: | Kim, Seth, Federman, Noah, Gordon, Erlinda M., Hall, Frederick L., Chawla, Sant P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451875/ https://www.ncbi.nlm.nih.gov/pubmed/28588778 http://dx.doi.org/10.3892/mco.2017.1231 |
Ejemplares similares
-
A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer
por: Chawla, Sant P., et al.
Publicado: (2018) -
Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer
por: Chawla, Sant P, et al.
Publicado: (2009) -
Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma
por: Chawla, Sant P, et al.
Publicado: (2009) -
CT of malignant peripheral nerve sheath tumor
por: Lugo-Fagundo, Elias, et al.
Publicado: (2022) -
Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients
por: Shurell, Elizabeth, et al.
Publicado: (2014)